Rennova Health, Inc. (RNVA)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 5, 2026, 4:00 PM EST

Rennova Health Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
18.6918.6913.043.227.216
Revenue Growth
43.34%43.34%304.36%-55.22%-55.01%10.00%
Gross Profit
11.1111.116.27-2.07-4.581.24
Operating Income
1.371.37-1.42-10.22-16.95-15.45
Net Income
-7.73-7.73-334.17-500.87-281.59-171.9
Earnings Per Share
-0.00-0.00-0.03-913.37--
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Investments
0.050.050.50.720.030.02
Total Debt
11.7811.7815.1116.0622.0250.22
Net Cash (Debt)
-11.73-11.73-14.61-15.33-22-50.2
Net Cash Growth
------
Net Cash Per Share
-0.00-0.00-0.00-27.96--

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Cash Flow
3.393.39-0.22-8.91-16.93-13.53
Capital Expenditures
-0.35-0.35-0.04--0.37-0
Free Cash Flow
3.043.04-0.25-8.91-17.3-13.53
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Gross Margin
59.46%59.46%48.08%-64.16%-63.66%7.77%
Operating Margin
7.31%7.31%-10.88%-317.00%-235.35%-96.54%
Pretax Margin
-1.68%-1.68%-23.30%-157.97%-263.22%-291.08%
Profit Margin
-41.36%-41.36%-2563.40%-15536.23%-3910.97%-1074.12%
FCF Margin
16.25%16.25%-1.94%-276.46%-240.26%-84.54%